A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors

  1. Khaki, A.R.
  2. Li, A.
  3. Diamantopoulos, L.N.
  4. Miller, N.J.
  5. Carril-Ajuria, L.
  6. Castellano, D.
  7. De Kouchkovsky, I.
  8. Koshkin, V.
  9. Park, J.
  10. Alva, A.
  11. Bilen, M.A.
  12. Stewart, T.
  13. Santos, V.
  14. Agarwal, N.
  15. Jain, J.
  16. Zakharia, Y.
  17. Morales-Barrera, R.
  18. Devitt, M.
  19. Nelson, A.
  20. Hoimes, C.J.
  21. Shreck, E.
  22. Gartrell, B.A.
  23. Sankin, A.
  24. Tripathi, A.
  25. Zakopoulou, R.
  26. Bamias, A.
  27. Rodriguez-Vida, A.
  28. Drakaki, A.
  29. Liu, S.
  30. Kumar, V.
  31. Lythgoe, M.P.
  32. Pinato, D.J.
  33. Murgic, J.
  34. Fröbe, A.
  35. Joshi, M.
  36. Isaacsson Velho, P.
  37. Hahn, N.
  38. Alonso Buznego, L.
  39. Duran, I.
  40. Moses, M.
  41. Barata, P.
  42. Galsky, M.D.
  43. Sonpavde, G.
  44. Yu, E.Y.
  45. Shankaran, V.
  46. Lyman, G.H.
  47. Grivas, P.
  48. Show all authors +
Journal:
European urology oncology

ISSN: 2588-9311

Year of publication: 2021

Volume: 4

Issue: 3

Pages: 464-472

Type: Article

DOI: 10.1016/J.EUO.2020.12.006 GOOGLE SCHOLAR

Sustainable development goals